Bibcode:2011ChEuJ..1710151H
Yokoi, K., Ito, T., Maeda, Y., Nakajima, Y., Ueta, A., Nomura, T., Koyama, N., Kato, I., Suzuki, S., Kurono, Y., Sugiyama, N., and Togari, H
The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases
241 GLP-1(936) promotes the undocking of secretory granules (SG) by inhibiting the entry of Ca 2+ through voltage-gated Ca 2+ channels
Neuropharmacology (2014) 76(Pt A):5767
This may be of benefit for anyone with MCAS, and clinical trials are looking at the effectiveness of different doses.[ref][ref] ( Related article: MCAS) Immune system modulation: The receptor for GLP-1 is found on the cell membrane of macrophages, regulatory T cells, and natural killer T cells